journal
Journals Clinical and Experimental Derm...

Clinical and Experimental Dermatology

https://read.qxmd.com/read/38762899/the-prevalence-of-body-dysmorphic-disorder-in-outpatient-dermatology-clinics-a-systematic-review
#41
JOURNAL ARTICLE
Namir Saade, Celine P Chedraoui, Marie Therese Mitri, Pascale Salameh, Yana Said, Jinane E El Khoury
Body Dysmorphic Disorder (BDD) is a psychiatric condition involving a preoccupation with physical appearance disproportionate to physical findings, which are often absent altogether. Previously published data has estimated its prevalence at 11.3-11.9% approximately, across various medical specialties. No recent systematic reviews strictly related to dermatology clinics and the prevalence of BDD have been published. The goal of the review was to gather a pooled prevalence of BDD in outpatient dermatology clinics around the world and further underline the importance of its recognition and appropriate treatment...
May 19, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38757196/national-epidemiology-of-digital-papillary-adenocarcinoma-in-england-2013-2020-a-population-based-registry-study
#42
JOURNAL ARTICLE
Kashini Andrew, Birgitta van Bodegraven, Sally Vernon, Mariam Balogun, Paul Craig, Neil Rajan, Zoe C Venables, Simon Tso
BACKGROUND: Digital papillary adenocarcinoma (DPA), formerly known as aggressive DPA, is a rare adnexal cancer of sweat gland differentiation with metastatic potential. DPA epidemiology and patient outcome data are a prerequisite to develop diagnostic and therapeutic guidance, which is lacking for this rare cancer. OBJECTIVES: To report the incidence, patient demographics and treatment of patients with DPA in England from 1 January 2013 to 31 December 2020 using national cancer registry data...
May 17, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38752380/general-dermatology-and-dermatology-in-primary-health-care
#43
JOURNAL ARTICLE
Sophie Diong, Lisa Murphy, Susan O'Gorman
No abstract text is available yet for this article.
May 16, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38751343/disagreement-concerning-atopic-dermatitis-subtypes-between-an-english-prospective-cohort-alspac-and-linked-electronic-health-records
#44
JOURNAL ARTICLE
Julian Matthewman, Amy Mulick, Nick Dand, Daniel Major-Smith, Alasdair Henderson, Neil Pearce, Spiros Denaxas, Rita Iskandar, Amanda Roberts, Rosie P Cornish, Sara J Brown, Lavinia Paternoster, Sinéad M Langan
BACKGROUND: Subtypes of atopic dermatitis (AD) have been derived from the Avon Longitudinal Study of Parents and Children (ALSPAC) based on presence and severity of symptoms reported in questionnaires (Severe-Frequent, Moderate-Frequent, Moderate-Declining, Mild-Intermittent, Unaffected/Rare). Good agreement between ALSPAC and linked electronic health records (EHRs) would increase trust in the clinical validity of these subtypes and allow inferring subtypes from EHRs alone, which would enable their study in large primary care databases...
May 16, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38751333/gaining-exposure-on-perceptions-of-sunscreen-a-national-survey-of-melanoma-patients
#45
JOURNAL ARTICLE
Sami A Raza, Diane Cannon, Faisal R Ali
Melanoma incidence is increasing. We ascertained perceptions regarding sunscreen and factors influencing choice in patients with melanoma. A survey was distributed to all the supporters of a melanoma patient support group. 571 responses were received across six weeks. Most (79.2%; n=452) indicated they knew how much sunscreen to apply; the most popular frequency of application was once daily (32%, n=180). The most popular cosmetic benefit respondents indicated was reduced redness on sun-exposed areas of skin (73...
May 16, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38747398/risk-factors-for-the-development-of-stevens-johnson-syndrome-toxic-epidermal-necrolysis-following-drug-administration-a-systematic-review-and-meta-analysis
#46
JOURNAL ARTICLE
Samaah Fathima, Matthew J Grainge, Hannah Wainman, Mikolaj Swiderski, Sonia Gran
No abstract text is available yet for this article.
May 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38747386/patient-initiated-follow-up-for-high-risk-cutaneous-squamous-cell-carcinoma-how-we-do-it-and-two-years-of-outcome-data
#47
JOURNAL ARTICLE
Shafiah Muna Abdul Gafoor, Sophie Robinson, Sofya Diskantova, Emma Woodcock, Sonam Yethenpa, Sophie Holloran, Toby Nelson
Why do we follow-up patients with high-risk cutaneous squamous-cell carcinomas (cSCC)? Current guidance suggests we offer post-treatment follow-up appointments at regular intervals for 24 months. Is this to improve prognosis, provide psychological support or find the next cancer? Recent data confirms recurrence and metastasis to be rarer events. We question whether these follow-up practices are truly 'needed' by introducing an option of patient-initiated follow-up (PIFU). We enrolled 476 cSCC patients (January 2020 - January 2023) who fulfilled the definition of high-risk cSCC based on guidelines in use at the time...
May 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38747355/porokeratosis
#48
JOURNAL ARTICLE
Andrew Awad, Alexander Nirenberg, Themis Getsos Colla, Rodney Sinclair
No abstract text is available yet for this article.
May 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38747191/a-galling-connection-an-unusual-lesion-on-the-abdomen-of-a-101-year-old-lady
#49
JOURNAL ARTICLE
Aswatha Rabindranathnambi, Anusha Panthagani, Kid Wan Shum
No abstract text is available yet for this article.
May 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38747180/recalcitrant-acneiform-papules-on-the-face
#50
JOURNAL ARTICLE
Sushant Agrawal, Sudheer Arava, Nikhil Mehta
No abstract text is available yet for this article.
May 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38747172/loss-of-function-filaggrin-mutations-are-associated-with-reduced-history-of-acne-vulgaris-in-a-cohort-of-bangladeshi-atopic-eczema-patients-in-east-london
#51
JOURNAL ARTICLE
Aaron J Hughes, Elsa Barbosa, Jeva Cernova, Bjorn R Thomas, Ryan F L O'Shaughnessy, Edel A O'Toole
Acne vulgaris (AV) is the eighth most common non-fatal disease globally. Previous work identified an association between AV and increased Filaggrin (FLG) expression in the follicular epidermis, but further work did not find a clear link between loss of function (LoF) Filaggrin gene (FLG) mutations and protection from AV. In this work we aimed to explore any association between AV and FLG LoF mutations using a cohort of genotyped Bangladeshi patients with atopic eczema (AE) in East London. Retrospective notes review was performed on 245 patients who had been genotyped for FLG LoF mutations and undergone clinical assessment...
May 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38742592/youtube-as-a-source-of-information-for-self-skin-examinations-an-analysis-of-content-and-quality
#52
JOURNAL ARTICLE
Yanci A Algarin, Anika Pulumati, Alex Reznik, Robert J Pariser
No abstract text is available yet for this article.
May 14, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739726/qualitative-investigation-of-disease-course-characteristics-and-lived-experience-of-generalized-pustular-psoriasis
#53
JOURNAL ARTICLE
Emily A Parks, Mallory L Zaino, Bettina Trettin, Steven R Feldman
BACKGROUND: Generalized pustular psoriasis (GPP) is a relapsing-remitting chronic disease characterized by painful pustules with systemic symptoms that negatively impacts quality of life. The psychosocial and economic burden of this rare condition is not well characterized. OBJECTIVES: To qualitatively characterize the cumulative burden of generalized pustular psoriasis on patients' quality of life and psychosocial wellbeing. METHODS: A retrospective chart review of patients with generalized pustular psoriasis was performed to collect demographic information, followed by prospective semi-structured clinical interviews...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739703/psychosocial-comorbidities-in-patients-with-pediatric-alopecia-areata-a-literature-review
#54
JOURNAL ARTICLE
Zane Sejdiu, Samantha Hess, Mohammad Jafferany
BACKGROUND: Alopecia areata (AA), a chronic autoimmune disorder causing non-scarring hair loss, has a greater prevalence in the pediatric population. Like many visible dermatologic disorders, AA can cause significant psychosocial impairment, particularly in children who are undergoing critical periods of psychosocial development. This paper investigates the psychosocial impact of AA on children. METHODS: A systematic review was conducted using PRISMA guidelines...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739692/disseminated-verrucous-and-keratotic-plaques-in-a-young-boy
#55
JOURNAL ARTICLE
Kittu Malhi, Sukhdeep Singh, Debajyoti Chatterjee, Dipankar De, Sanjeev Handa, Rahul Mahajan
No abstract text is available yet for this article.
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38739553/exploring-the-burden-of-actinic-keratoses-through-development-of-a-patient-decision-aid-a-mixed-methods-study
#56
JOURNAL ARTICLE
Ciara Drumm, Aoife Moloney, Louise Fleming, Imelda Morgan, Ciara Keating, Clodagh Hughes, Roisin Dolan, Bláithín Moriarty, Aoife Lally
BACKGROUND: Actinic keratoses (AKs) present on sun-exposed sites and are considered precursors of cutaneous squamous cell carcinoma (cSCC). A better understanding of the experiences of patients with this condition may improve patient-provider relationships and guide the introduction of shared-decision making (SDM) to treatment decisions. OBJECTIVES: To develop a patient decision aid (PDA) for field treatment of multiple actinic keratoses in line with the International Patient Decision Aid Standards (IPDAS), by (i) characterising the burden and lived experiences of patients with multiple AKs, (ii) understanding the decisional needs of patients requiring field treatment and (iii) exploring clinician preferences regarding field treatment for multiple AKs...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38738509/a-solitary-erythematous-plaque
#57
JOURNAL ARTICLE
Nikita Cliff-Patel, Emma Amoafo, Lorette Ffolkes, Victoria Akhras
No abstract text is available yet for this article.
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38738507/neuro-sweet-syndrome
#58
JOURNAL ARTICLE
Krishna Thazhatheyil, Marese O'Reilly, Nikolas Rae, Sharon Edwards, Jonathan O'Riordan, Andrew Affleck
No abstract text is available yet for this article.
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38738503/primary-cutaneous-cd4-small-medium-t-cell-lymphoproliferative-disorders-smplpd-demographical-clinical-therapeutic-and-prognostic-aspects-a-retrospective-monocentric-analysis
#59
JOURNAL ARTICLE
Corrado Zengarini, Alba Guglielmo, Giulia Bandini, Andrea Filippini, Martina Mussi, Claudio Agostinelli, Elena Sabattini, Bianca Maria Piraccini, Alessandro Pileri
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), also known as PCS-TCLPD, represent a rare group of hematologic diseases primarily affecting the skin. In this retrospective single-centre case series study, we aimed to investigate the demographic, clinical, therapeutic, and prognostic aspects of SMPLPD. We collected data from cases diagnosed between 2010 and the present, employing histopathological and immunohistochemical methods following WHO criteria. We included 22 patients with a median age of 61...
May 13, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38738498/secondary-oral-squamous-cell-carcinoma-following-haematopoietic-stem-cell-transplantation
#60
JOURNAL ARTICLE
Faaris Zaki, Martina Shephard, Robert Danby, Rachel Pawson, Andy Peniket, Katharine Sheppard, Rubeta N Matin
We report 10 cases of oral squamous cell carcinoma (SCC) post-haematopoietic stem cell transplant (HSCT).. Median latency from HSCT to oral SCC diagnosis was 10 years (range: 4-17 years) with 90% reporting a history of chronic graft-versus-host disease (cGVHD) and 40% exhibited active severe manifestations of oral GVHD. Clinical findings at diagnosis included induration, ulceration, tenderness, bleeding, hyperkeratosis, speckling and lymphadenopathy. The tongue and buccal mucosa were the commonest sites affected...
May 13, 2024: Clinical and Experimental Dermatology
journal
journal
26722
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.